The Stock2Me Podcast

Stock2Me’s latest podcast features Murray Thom, Vice President of Quantum Technology Evangelism at D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems within logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. To begin the interview, Thom discussed some of the primary goals of D-Wave’s Qubits Conference, which took place June 17 and 18, 2024 in Boston and virtually. “Qubits is the premier quantum computing event of the year. We have thousands of people who are watching online and hundreds of people who come out to join us,” he said. “The main goals of the conference are focusing on success powered by quantum, which is on full display here. We're trying to share with the community how much commercial adoption there is with quantum computing and how businesses have been successful building business value using quantum computing technology. We're also sharing our latest product innovations, because attendees are really curious to see the rapid pace of change with quantum computing and what's possible there.” “I'm really excited about the presentation from Carleton Coffrin. He's going to be presenting from Los Alamos National Laboratory about new quantum materials discovery using our quantum computing systems… We're also going to be seeing some demos from Alex Condello, who is leading our applications performance and tools team. He's going to be talking about some of our latest hybrid solver technology and how that's making it easier for people to solve business problems at larger scale and get high quality value.” Please see full terms of use and disclaimers on the IBN website applicable to all content provided by IBN, wherever published or re-published: https://IBN.fm/Disclaimer

Stock2Me’s latest podcast features Murray Thom, Vice President of Quantum Technology Evangelism at D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems within logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. To begin the interview, Thom discussed some of the primary goals of D-Wave’s Qubits Conference, which took place June 17 and 18, 2024 in Boston and virtually. “Qubits is the premier quantum computing event of the year. We have thousands of people who are watching online and hundreds of people who come out to join us,” he said. “The main goals of the conference are focusing on success powered by quantum, which is on full display here. We're trying to share with the community how much commercial adoption there is with quantum computing and how businesses have been successful building business value using quantum computing technology. We're also sharing our latest product innovations, because attendees are really curious to see the rapid pace of change with quantum computing and what's possible there.” “I'm really excited about the presentation from Carleton Coffrin. He's going to be presenting from Los Alamos National Laboratory about new quantum materials discovery using our quantum computing systems… We're also going to be seeing some demos from Alex Condello, who is leading our applications performance and tools team. He's going to be talking about some of our latest hybrid solver technology and how that's making it easier for people to solve business problems at larger scale and get high quality value.” Please see full terms of use and disclaimers on the IBN website applicable to all content provided by IBN, wherever published or re-published: https://IBN.fm/Disclaimer

The Stock2Me Podcast’s latest audio production features Brian J. Esposito, CEO of Diamond Lake Minerals Inc. (OTC: DLMI), a multi-strategy operating company offering traditional investors an entry point to the future of digital securities. To begin the interview, Esposito discussed his background prior to joining Diamond Lake Minerals. “My entire career has been as an entrepreneur. As a teenager, I was starting companies, going out there and finding ways to earn, and I've been doing that until present day,” Esposito said. “There are two channels of my life. With my private holdings company, Esposito Intellectual Enterprises, I’ve worked for 23+ years as an entrepreneur – building, starting, acquiring and merging with companies. The current arsenal there that I've built up is over 110 companies that we're involved in. There are over 200 joint ventures around the world proudly operating in over 25 different industries.” “I've always been heavily focused on public markets – understanding regulatory requirements and always treating companies as if they were public companies as far as being fully audited. I'm not the unicorn guy. I'm the guy that says if you want to be in business, you've got to have revenues. If you want to stay in business, you need to be profitable. That's the simplest definition of business that I can think of.” “The opportunity arose to look at DLMI and take over as CEO last August. I’ve been presented so many public vehicles and OTC or pink sheets throughout my career, and they’re always a mess riddled with billions of shares. DLMI was quite special. I aligned with President and Director Michael Reynolds to come up with the strategy of repurposing and re-strategizing the vision of the company, taking my history and my expertise, especially in digital assets and security tokens, and applying a new model of what I believe to be the future of public companies.” Join IBN’s Jonathan Keim and Stock2Me’s latest guest to learn more about DLMI’s initiatives in tokenization, as well as its recent partnerships, investments and milestones. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: https://IBN.fm/Disclaimer

The Stock2Me Podcast’s latest audio production features Brian J. Esposito, CEO of Diamond Lake Minerals Inc. (OTC: DLMI), a multi-strategy operating company offering traditional investors an entry point to the future of digital securities. To begin the interview, Esposito discussed his background prior to joining Diamond Lake Minerals. “My entire career has been as an entrepreneur. As a teenager, I was starting companies, going out there and finding ways to earn, and I've been doing that until present day,” Esposito said. “There are two channels of my life. With my private holdings company, Esposito Intellectual Enterprises, I’ve worked for 23+ years as an entrepreneur – building, starting, acquiring and merging with companies. The current arsenal there that I've built up is over 110 companies that we're involved in. There are over 200 joint ventures around the world proudly operating in over 25 different industries.” “I've always been heavily focused on public markets – understanding regulatory requirements and always treating companies as if they were public companies as far as being fully audited. I'm not the unicorn guy. I'm the guy that says if you want to be in business, you've got to have revenues. If you want to stay in business, you need to be profitable. That's the simplest definition of business that I can think of.” “The opportunity arose to look at DLMI and take over as CEO last August. I’ve been presented so many public vehicles and OTC or pink sheets throughout my career, and they’re always a mess riddled with billions of shares. DLMI was quite special. I aligned with President and Director Michael Reynolds to come up with the strategy of repurposing and re-strategizing the vision of the company, taking my history and my expertise, especially in digital assets and security tokens, and applying a new model of what I believe to be the future of public companies.” Join IBN’s Jonathan Keim and Stock2Me’s latest guest to learn more about DLMI’s initiatives in tokenization, as well as its recent partnerships, investments and milestones. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: https://IBN.fm/Disclaimer

DeFi Technologies Inc. (NEO: DEFI) (GR: RB9) (OTC: DEFTF), a crypto native technology company that pioneers the convergence of traditional capital markets with the world of decentralized finance, recently announced that its subsidiary, Valour Inc., and Valour Digital Securities Limited (together, “Valour”), a leading issuer of exchange traded products (“ETPs”) that provide simplified access to digital assets, reported a 47.2% year-over-year increase of assets under management ("AUM") to C$748 million as of May 7, 2024. "We are very encouraged by the strong year-on-year growth of our AUM, which reflects the sustained demand for our innovative ETP products and trust from our investors," Olivier Roussy Newton, CEO of DeFi Technologies, stated in the news release. "Our strategic expansions and the introduction of groundbreaking products this month underscore our commitment to providing secure, diversified, and accessible digital asset investment options. We are excited about our future prospects and remain dedicated to advancing our position in the digital asset space." To read the original press release, visit: https://nnw.fm/P1Ue1 Please see full terms of use and disclaimers on the IBN website applicable to all content provided by IBN, wherever published or re-published: https://IBN.fm/Disclaimer

DeFi Technologies Inc. (NEO: DEFI) (GR: RB9) (OTC: DEFTF), a crypto native technology company that pioneers the convergence of traditional capital markets with the world of decentralized finance, recently announced that its subsidiary, Valour Inc., and Valour Digital Securities Limited (together, “Valour”), a leading issuer of exchange traded products (“ETPs”) that provide simplified access to digital assets, reported a 47.2% year-over-year increase of assets under management ("AUM") to C$748 million as of May 7, 2024. "We are very encouraged by the strong year-on-year growth of our AUM, which reflects the sustained demand for our innovative ETP products and trust from our investors," Olivier Roussy Newton, CEO of DeFi Technologies, stated in the news release. "Our strategic expansions and the introduction of groundbreaking products this month underscore our commitment to providing secure, diversified, and accessible digital asset investment options. We are excited about our future prospects and remain dedicated to advancing our position in the digital asset space." To read the original press release, visit: https://nnw.fm/P1Ue1 Please see full terms of use and disclaimers on the IBN website applicable to all content provided by IBN, wherever published or re-published: https://IBN.fm/Disclaimer

Stock2Me’s latest podcast features Dr. Alan Baratz, CEO of D-Wave Quantum Inc. (NYSE: QBTS), a leader in quantum computing systems, software and services that delivers customer value via practical quantum applications for computationally complex problems such as factory planning, resource allocation, job shop scheduling, labor allocation, vehicle routing, artificial intelligence, drug discovery, financial modeling and more. During the interview, Dr. Baratz discussed his journey to becoming the CEO of D-Wave, provided an introduction to quantum computing and offered perspectives on D-Wave’s leadership in driving the commercial adoption of this emerging technology. “Quantum computing is nothing more than using quantum mechanical effects – things like superposition, entanglement or tunneling – to solve computationally hard problems faster or better than they can be solved using classical computers. Quantum computing can be applied to both revolutionary applications, like developing designer drugs or global weather modeling, and evolutionary applications, like improving employee scheduling or autonomous vehicle routing on manufacturing plant floors. These evolutionary applications are problems that businesses are solving today; it's just that they're computationally so hard that businesses are using heuristics to try to come up with what they hope are ‘good enough’ solutions. With quantum computing, we're able to deliver better solutions faster to those problems.” “Quantum computing is crossing the chasm right now, from experimentation to enterprise usage. At D-Wave, we took a different approach to quantum computing from everybody else in the industry; we decided to start with annealing quantum computing. Annealing is a much easier technology to work with, it's easier to scale and much less sensitive to errors. That has allowed us to become commercial today. D-Wave is actually driving adoption in the market with real customers who have applications in production today, helping to benefit their business operations. Nobody else in the quantum industry can say that.” Please see full terms of use and disclaimers on the IBN website applicable to all content provided by IBN, wherever published or re-published: https://IBN.fm/Disclaimer

Stock2Me’s latest podcast features Dr. Alan Baratz, CEO of D-Wave Quantum Inc. (NYSE: QBTS), a leader in quantum computing systems, software and services that delivers customer value via practical quantum applications for computationally complex problems such as factory planning, resource allocation, job shop scheduling, labor allocation, vehicle routing, artificial intelligence, drug discovery, financial modeling and more. During the interview, Dr. Baratz discussed his journey to becoming the CEO of D-Wave, provided an introduction to quantum computing and offered perspectives on D-Wave’s leadership in driving the commercial adoption of this emerging technology. “Quantum computing is nothing more than using quantum mechanical effects – things like superposition, entanglement or tunneling – to solve computationally hard problems faster or better than they can be solved using classical computers. Quantum computing can be applied to both revolutionary applications, like developing designer drugs or global weather modeling, and evolutionary applications, like improving employee scheduling or autonomous vehicle routing on manufacturing plant floors. These evolutionary applications are problems that businesses are solving today; it's just that they're computationally so hard that businesses are using heuristics to try to come up with what they hope are ‘good enough’ solutions. With quantum computing, we're able to deliver better solutions faster to those problems.” “Quantum computing is crossing the chasm right now, from experimentation to enterprise usage. At D-Wave, we took a different approach to quantum computing from everybody else in the industry; we decided to start with annealing quantum computing. Annealing is a much easier technology to work with, it's easier to scale and much less sensitive to errors. That has allowed us to become commercial today. D-Wave is actually driving adoption in the market with real customers who have applications in production today, helping to benefit their business operations. Nobody else in the quantum industry can say that.” Please see full terms of use and disclaimers on the IBN website applicable to all content provided by IBN, wherever published or re-published: https://IBN.fm/Disclaimer

Stock2Me’s latest podcast features Joel Fruendt, President and CEO of SenesTech Inc. (NASDAQ: SNES), the leader in fertility control to manage animal pest populations. To begin the interview, Fruendt provided an introduction to SenesTech’s business model and operating markets. “SenesTech is a biotech and life sciences company that develops, patents and commercializes product formulations for fertility control of animal pests. Our mission is improving the health of our world by humanely managing animal pest populations through fertility control,” Fruendt said. “We're addressing one of the world's oldest and most challenging problems, and that's rodent control. We're doing this through a completely different way than has ever been done before by addressing the root cause of the problem, which is reproduction.”

Stock2Me’s latest podcast features Joel Fruendt, President and CEO of SenesTech Inc. (NASDAQ: SNES), the leader in fertility control to manage animal pest populations. To begin the interview, Fruendt provided an introduction to SenesTech’s business model and operating markets. “SenesTech is a biotech and life sciences company that develops, patents and commercializes product formulations for fertility control of animal pests. Our mission is improving the health of our world by humanely managing animal pest populations through fertility control,” Fruendt said. “We're addressing one of the world's oldest and most challenging problems, and that's rodent control. We're doing this through a completely different way than has ever been done before by addressing the root cause of the problem, which is reproduction.”

Stock2Me’s latest podcast features M.E. Tuthill, a financial writer and journalist and author of Repo-Madness: A Simpleton’s Guide to the Street’s Wicked Ways, a book aiming to blow the lid off what has come to be known as the shadow banking system. To begin the interview, Tuthill discussed her background. “I was born and raised outside of Boston, Massachusetts, and I spent the earlier part of my career in broadcasting as a radio journalist. After 10 years of that… I was ready for a change. I decided to take a big leap – and I mean big… I decided to become a financial advisor,” Tuthill said. “I did that for 13 years, and it was a really good experience. I learned a lot about money. Ironically, though, I was in all these brokerage firms, and I knew nothing about what I’m now writing about, which is the huge market and the financial system.” “After 13 years, I’d had enough of that… I got a position as a financial writer at iMoneyNet… I wrote articles about money market funds. When I first got the job I thought, ‘Oh this is great, I’ve got a 9-to-5 and a steady paycheck,’ but money market funds weren’t really that exciting to write about. When the financial crisis hit, everything changed. Those funds had such an integral role in what happened. For the next nine years after that happened, I wrote every week and every day about the money market funds and the shadow banking system in general. I got addicted to it; I got hooked on it.” Tuthill then provided an introduction to Repo-Madness: A Simpleton’s Guide to the Street’s Wicked Ways by discussing the concept of shadow banking.

Stock2Me’s latest podcast features M.E. Tuthill, a financial writer and journalist and author of Repo-Madness: A Simpleton’s Guide to the Street’s Wicked Ways, a book aiming to blow the lid off what has come to be known as the shadow banking system. To begin the interview, Tuthill discussed her background. “I was born and raised outside of Boston, Massachusetts, and I spent the earlier part of my career in broadcasting as a radio journalist. After 10 years of that… I was ready for a change. I decided to take a big leap – and I mean big… I decided to become a financial advisor,” Tuthill said. “I did that for 13 years, and it was a really good experience. I learned a lot about money. Ironically, though, I was in all these brokerage firms, and I knew nothing about what I’m now writing about, which is the huge market and the financial system.” “After 13 years, I’d had enough of that… I got a position as a financial writer at iMoneyNet… I wrote articles about money market funds. When I first got the job I thought, ‘Oh this is great, I’ve got a 9-to-5 and a steady paycheck,’ but money market funds weren’t really that exciting to write about. When the financial crisis hit, everything changed. Those funds had such an integral role in what happened. For the next nine years after that happened, I wrote every week and every day about the money market funds and the shadow banking system in general. I got addicted to it; I got hooked on it.” Tuthill then provided an introduction to Repo-Madness: A Simpleton’s Guide to the Street’s Wicked Ways by discussing the concept of shadow banking.

Stock2Me’s latest podcast features the return of David Jemmett, CEO and Founder of CISO Global Inc. (NASDAQ: CISO), an industry leader in cybersecurity and compliance services. Throughout the interview, Jemmett discussed the current state of the cybersecurity industry and CISO’s expanding position within it. “Here’s a rhetorical question: Are we doing cybersecurity correctly today? No. With $6 trillion lost last year, we only spent $282 billion; we have to do something to catch up with or surpass the bad guys. We have to come up with new, innovative methods, and, with a talent shortage of four million jobs, we also have to train and enhance what we’re doing to protect not only our customers, but ourselves,” Jemmett said. “Since CISO was incepted, we self-funded ourselves through the OTC and bought 12 companies on a global basis. In January 2022, we uplisted to Nasdaq. Since then, we’ve acquired a total of 18 organizations, stock-for-stock, and brought some of the brightest stars in cybersecurity and compliance spanning three separate continents to our organization.” Join IBN’s Stuart Smith and David Jemmett to learn more about the company’s recent milestones and explore the ways CISO ensures compliance with evolving industry standards and regulations.

Stock2Me’s latest podcast features the return of David Jemmett, CEO and Founder of CISO Global Inc. (NASDAQ: CISO), an industry leader in cybersecurity and compliance services. Throughout the interview, Jemmett discussed the current state of the cybersecurity industry and CISO’s expanding position within it. “Here’s a rhetorical question: Are we doing cybersecurity correctly today? No. With $6 trillion lost last year, we only spent $282 billion; we have to do something to catch up with or surpass the bad guys. We have to come up with new, innovative methods, and, with a talent shortage of four million jobs, we also have to train and enhance what we’re doing to protect not only our customers, but ourselves,” Jemmett said. “Since CISO was incepted, we self-funded ourselves through the OTC and bought 12 companies on a global basis. In January 2022, we uplisted to Nasdaq. Since then, we’ve acquired a total of 18 organizations, stock-for-stock, and brought some of the brightest stars in cybersecurity and compliance spanning three separate continents to our organization.” Join IBN’s Stuart Smith and David Jemmett to learn more about the company’s recent milestones and explore the ways CISO ensures compliance with evolving industry standards and regulations.

Stock2Me’s latest podcast features Rod Turner, CEO and Founder of Manhattan Street Capital, the premier growth capital platform for midsize and startup companies. Throughout the interview, Turner discussed his professional background – from his time as an engineer to his successful track record as an entrepreneur – before examining why he founded Manhattan Street Capital. “In March 2015, Reg A+ was announced, and it went effective in late June. When I read the regulation, I was shocked and impressed by how well-written it is,” Turner said. “Having raised money and invested money in startup companies over so many years and such a large portion of my business life, I’m aware of how the current lending climate for capital raising was limiting lots of great companies that could otherwise justify and deploy growth capital successfully and make public offerings successfully. Reg A+ provided a phenomenally great way to up the ante and improve the situation… The timing was great, so I decided to found Manhattan Street Capital in May 2015 – about a month before Reg A+ became effective. We were the first Reg A+-focused offering platform in what is essentially crowd investing. I believe that Reg A+, when it hits stride, will be a very, very large segment of the capital-raising industry.” Join IBN’s Stuart Smith and Rod Turner to learn more about the rapid growth of the Reg A+ space and the trends guiding the online capital formation business in 2023.

Stock2Me’s latest podcast features Rod Turner, CEO and Founder of Manhattan Street Capital, the premier growth capital platform for midsize and startup companies. Throughout the interview, Turner discussed his professional background – from his time as an engineer to his successful track record as an entrepreneur – before examining why he founded Manhattan Street Capital. “In March 2015, Reg A+ was announced, and it went effective in late June. When I read the regulation, I was shocked and impressed by how well-written it is,” Turner said. “Having raised money and invested money in startup companies over so many years and such a large portion of my business life, I’m aware of how the current lending climate for capital raising was limiting lots of great companies that could otherwise justify and deploy growth capital successfully and make public offerings successfully. Reg A+ provided a phenomenally great way to up the ante and improve the situation… The timing was great, so I decided to found Manhattan Street Capital in May 2015 – about a month before Reg A+ became effective. We were the first Reg A+-focused offering platform in what is essentially crowd investing. I believe that Reg A+, when it hits stride, will be a very, very large segment of the capital-raising industry.” Join IBN’s Stuart Smith and Rod Turner to learn more about the rapid growth of the Reg A+ space and the trends guiding the online capital formation business in 2023.

Stock2Me’s latest podcast features David Jemmett, CEO and Founder of Cerberus Cyber Sentinel Corp. (NASDAQ: CISO) (“CISO Global” or the “Company”), an industry leader in cybersecurity and compliance services. Throughout the interview, Jemmett discussed the core values and mission of Cerberus Sentinel. “Cerberus Sentinel was founded at a period of time when there were 800,000 job openings in cyber. There’s been a zero jobless rate since 2011. This year alone there are four million job openings [in cyber] globally,” Jemmett said. “A lot of my friends and coworkers have started cybersecurity companies in the past, but they were very verticalized – training, gap analysis, compliance or SOC services… At Cerberus Sentinel, we help our clients find their cyber issues, remediate them and keep on top of them. Cybersecurity is a journey; it’s not an endpoint. We’ll continue to work on the evolving threat matrix with our customers to help them keep improving.” Join IBN’s Stuart Smith and David Jemmett to learn more about the company’s unique offerings in the cyber space and how they differentiate Cerberus Sentinel from the competition.

Stock2Me’s latest podcast features Amir Reichman, CEO of BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious diseases and autoimmune diseases. In this podcast episode, Reichman introduced the history of BiondVax leading up to his appointment as CEO before discussing the company’s recent development efforts focused on innovative nanosized antibody (NanoAb) therapies addressing diseases underserved by current treatments and with large and growing markets. “BiondVax is a biotechnology company focused on research and development. It is located in Jerusalem, Israel. It was founded about 17 years ago by an entrepreneur who took a spinoff from the Weizmann Institute of Science in Israel with a mission to develop a universal influenza vaccine,” Reichman said. “The vaccine was developed in the laboratory of Professor Ruth Arnon, a world-renowned professor and researcher mostly known for co-developing Copaxone, the multiple sclerosis drug marketed by Teva Pharmaceuticals. The universal influenza vaccine was then developed by BiondVax throughout the next 15 years, covering Preclinical, Phase I and multiple Phase II trials before ending up with a Phase III – the biggest Phase III ever conducted by an Israeli pharma company, with 12,400 participants spanning seven countries. The latest installment of The Stock2Me Podcast continues to reinforce IBN’s commitment to the expansion of its robust network of brands, client partners, followers and the growing IBN Podcast Series. For more than 15 years, IBN has leveraged this commitment to provide unparalleled distribution and corporate messaging solutions to 500+ public and private companies. To learn more about IBN’s achievements and milestones via a visual timeline, visit: https://IBN.fm/TimeLine

Stock2Me’s latest podcast features Amir Reichman, CEO of BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious diseases and autoimmune diseases. In this podcast episode, Reichman introduced the history of BiondVax leading up to his appointment as CEO before discussing the company’s recent development efforts focused on innovative nanosized antibody (NanoAb) therapies addressing diseases underserved by current treatments and with large and growing markets. “BiondVax is a biotechnology company focused on research and development. It is located in Jerusalem, Israel. It was founded about 17 years ago by an entrepreneur who took a spinoff from the Weizmann Institute of Science in Israel with a mission to develop a universal influenza vaccine,” Reichman said. “The vaccine was developed in the laboratory of Professor Ruth Arnon, a world-renowned professor and researcher mostly known for co-developing Copaxone, the multiple sclerosis drug marketed by Teva Pharmaceuticals. The universal influenza vaccine was then developed by BiondVax throughout the next 15 years, covering Preclinical, Phase I and multiple Phase II trials before ending up with a Phase III – the biggest Phase III ever conducted by an Israeli pharma company, with 12,400 participants spanning seven countries. The latest installment of The Stock2Me Podcast continues to reinforce IBN’s commitment to the expansion of its robust network of brands, client partners, followers and the growing IBN Podcast Series. For more than 15 years, IBN has leveraged this commitment to provide unparalleled distribution and corporate messaging solutions to 500+ public and private companies. To learn more about IBN’s achievements and milestones via a visual timeline, visit: https://IBN.fm/TimeLine

Stock2Me’s latest podcast features two-time Olympic gold medalist Abby Wambach speaking on behalf of Odyssey Health Inc. (OTC: ODYY), a medical technology company developing a drug/device combination intended to treat concussion. Wambach is a member of Odyssey’s sports advisory board, which aims to support the company’s efforts to enhance public awareness of traumatic brain injuries and concussions, as well as the need for an FDA-approved therapy. Throughout the interview, Wambach discussed her soccer career and how concerns about brain health led her to team with Odyssey Health. “I had a unique, long career playing for the Women’s National Team. I played in many Olympics and World Cups, won a bunch of golds and, in my retirement (I’ve been retired for six years), I’ve had a lot of time to reflect on the time that I played,” Wambach said. “I played soccer for 30 years, and one of the biggest concerns that I have going into the rest of my life is my brain health and wellness. Of course, a lot of us only think of concussions and CTE as it relates to NFL football, but the reality is that brain trauma happens in every sport.”